Does the presence of hibernating myocardium in patients with impaired left ventricular contraction affect QT dispersion?

American Heart Journal

Volumn 141, Issue 6, 2001, Pages 944-948

  Al Mohammad, Abdallah ^a   Mahy, Ian R ^a   Buckley, Aidan ^a   Cargill, Robert I ^a   Norton, Murdoch Y ^b   Welch, Andrew E ^b   Walton, Stephen ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; FLUORODEOXYGLUCOSE F 18; NITROGEN 13;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; MALE; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QT INTERVAL; VALIDATION PROCESS;

EID: 0035371008     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.114973     Document Type: Article

References (15)

1. Eitzman D, AI-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
2. Zabel M, Klingenheben T, Franz MR, et al. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 1998;97:2543-50.
3. Schneider CA, Voth E, Baer FM, et al. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction. Circulation 1997;96:3913-20.
4. Lemlek J, Heo J, Iskandian AS. The clinical relevance of myocardial viability in patient management. Am Heart J 1992;124:1327-31.
5. AI-Mohammad A, Mahy IR, Norton MY, et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart 1998;80:559-64.
6. Baer FM, Voth E, Schneider CA, et al. Comparison of low-dose dobutamine gradient-echo magnetic resonance imaging and positron emission tomography with [l 8F] fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation 1995;91:1006-15.
7. Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988;61:83-7.
8. Higham PD, Campbell RWF. QT dispersion. Br Heart J 1994;71:508-10.
9. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920;7:353-70.
10. Pye MP, Cobbe SM. Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res 1992;26:740-50.
11. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present and future prospects. Circulation 1987;75:IV-11-9.
12. Higham PD, Furniss SS, Campbell RW. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 1995;73:32-6.
13. Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9.
14. Puljevic D, Smalcelj A, Durakovic Z, et al. Effects of postmyocardial infarction scar size, cardiac function, and severity of coronary artery disease on QT interval dispersion as a risk factor for complex ventricular arrhythmia. Pacing Clin Electrophysiol 1998;21:1508-16.
15. vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.